1. Others
  2. Others

Others

Others Related Products (1054):

Cat. No. Product Name Effect Purity
  • HY-17031
    SBE-β-CD >98.0%
    SBE-β-CD is a sulfobutylether β-cyclodextrin derivative, it is an excipient or a formulating agent used to increase the solubility of poorly soluble drugs.
  • HY-15608
    MPTP hydrochloride Inhibitor 99.16%
    MPTP (hydrochloride) is a prodrug to the neurotoxin MPP which causes permanent symptoms of Parkinson's disease.
  • HY-B0579
    Cyclosporin A Inhibitor >98.0%
    Cyclosporin A is an immunosuppressive agent, binds to the cyclophilin and then inhibits calcineurin with IC50 of 7 nM.
  • HY-50202
    Etomoxir Inhibitor 99.40%
    Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
  • HY-50202A
    (R)-(+)-Etomoxir sodium salt 99.94%
    (R)-(+)-Etomoxir sodium salt is R-form of Etomoxir sodium salt.
  • HY-B0215
    Acetylcysteine Inhibitor 99.27%
    Acetylcysteine is a pharmaceutical drug and nutritional supplement used primarily as a mucolytic agent and in the management of paracetamol (acetaminophen) overdose.
  • HY-18597
    LB-100 Inhibitor >98.0%
    LB-100 is a water soluble protein phosphatase 2A (PP2A) inhibitor, with IC50 of 0.85 μM and 3.87 μM in BxPc-3 and Panc-1 cells.
  • HY-18729A
    L-NAME hydrochloride Inhibitor >98.0%
    L-NAME hydrochloride inhibits NOS with an IC50 of 70 μM.
  • HY-N0273
    Brassinolide Modulator >98.0%
    Brassinolide is a plant sterol first isolated from pollen of rape (Brassica napus L.), Brassinolide could promote stem elongation and cell division.
  • HY-12298
    GKT137831 Inhibitor 98.51%
    GKT137831 is a novel, specific dual NADPH oxidase (NOX1/4) inhibitor.
  • HY-B1123
    Auranofin Inhibitor >98.0%
    Auranofin (SKF-39162) is a thioredoxin reductase (TrxR) inhibitor with an IC50 of 0.2 μM.
  • HY-A0190
    Ceruletide 98.09%
    Ceruletide (Caerulein) is a biologically active decapeptide isolated from the skin of the Australian frog Hyla caerulea.
  • HY-12683
    BPTES Inhibitor 98.50%
    BPTES is a potent and selective allosteric inhibitor of kidney-type glutaminase (GLS) that has served as a molecular probe to determine the therapeutic potential of GLS inhibition.
  • HY-100410
    FCCP >98.0%
    FCCP is a mitochondrial uncoupling agent, used in cancer research.
  • HY-100218A
    RSL3 1S,3R- Inhibitor 99.59%
    RSL3 (1S,3R-) is the inhibitor of the glutathione (GSH) peroxidase 4, which can inhibit the cysteine/glutamate amino acid transporter system xc- that blocks GSH synthesis with an IC 50 of 100 nM.
  • HY-N0077
    Ginkgolic Acid Inhibitor
    Ginkgolic Acid is a natural compound with suspected cytotoxic, allergenic, mutagenic and carcinogenic properties.
  • HY-15775
    Arginase inhibitor 1 Inhibitor >98.0%
    Arginase inhibitor 1 is a potent inhibitor of human arginases I and II with IC50s of 223 and 509 nM, respectively.
  • HY-13005
    Fagomine Inhibitor >98.0%
    Fagomine is a mild glycosidase inhibitor.
  • HY-18950
    GSK2795039 Inhibitor 99.44%
    GSK2795039 is a novel small molecule NADPH Oxidase 2 Inhibitor.
  • HY-13541A
    Exherin trifluoroacetate Inhibitor
    Exherin (ADH-1) trifluoroacetate is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities; selectively and competitively binds to and blocks N-cadherin.